Search
forLearn
1 / 1 resultsResearch
5 / 1000+ results
research Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome
The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.
research Fractional Resurfacing in the Asian Patient: Current State of the Art
Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.
research Post-Traumatic Erosive Dermatosis of the Scalp: A Hypergranulated Variant
Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.
research Eyebrow Regrowth in Patient with Atrophic Scarring Alopecia Treated with an Autologous Fat Graft
research A 61-Year-Old Filipino Man with Lichen Planus Concomitant with Cicatricial Alopecia, Mimicking Discoid Lupus Erythematosus
A 61-year-old Filipino man had a skin condition that looked like another disease, making diagnosis difficult.
Community Join
3 / 3 resultscommunity Unofficial Dermapen/Roller Guide
Treatments for hair loss, including microneedling (dermarolling and dermapen) and the use of minoxidil, finasteride, and RU58841. It provides detailed information about cost and usage of the various treatments, as well as potential side effects.
community 3 months of microneedling, minox,& fin biotin. Zinc
User reports 3 months of microneedling, minoxidil, finasteride, biotin, and zinc for hair loss. Others comment on great progress and suggest checking back after 1 year.
community Long term finasteride users; Did you notice any improvement after 2 years?
Long term Finasteride users and whether or not they have noticed improvements after two years of use, with other treatments such as Minoxidil and dermarolling also discussed. Some replies suggest that improvement is possible even beyond the two year mark while others caution against believing studies backed by the Post-Finasteride Foundation.